Trial
NCT02377466
A Phase III Efficacy and Safety Study of Intravenous Retosiban Versus Placebo for Women in Spontaneous Preterm Labor
Phase IIITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
GlaxoSmithKline
Collaborators
PPD Development, LP
Condition
Obstetric Labour, Premature
Intervention
Retosiban IV infusion
Why stopped
Asset terminated by PIB
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2020-07-28